Archives of Virology

, Volume 158, Issue 3, pp 629–637 | Cite as

Protection of guinea pigs by vaccination with a recombinant swinepox virus co-expressing HA1 genes of swine H1N1 and H3N2 influenza viruses

  • Jiarong Xu
  • Deji Yang
  • Dongyan Huang
  • Jiaping Xu
  • Shichao Liu
  • Huixing Lin
  • Haodan Zhu
  • Bao Liu
  • Chengping Lu
Original Article
First Online:
Received:
Accepted:

Abstract

Swine influenza (SI) is an acute respiratory infectious disease of swine caused by swine influenza virus (SIV). SIV is not only an important respiratory pathogen in pigs but also a potent threat to human health. Here, we report the construction of a recombinant swinepox virus (rSPV/H3-2A-H1) co-expressing hemagglutinin (HA1) of SIV subtypes H1N1 and H3N2. Immune responses and protection efficacy of the rSPV/H3-2A-H1 were evaluated in guinea pigs. Inoculation of rSPV/H3-2A-H1 yielded neutralizing antibodies against SIV H1N1 and H3N2. The IFN-γ and IL-4 concentrations in the supernatant of lymphocytes stimulated with purified SIV HA1 antigen were significantly higher (P < 0.01) than those of the control groups. Complete protection of guinea pigs against SIV H1N1 or H3N2 challenge was observed. No SIV shedding was detected from guinea pigs vaccinated with rSPV/H3-2A-H1 after challenge. Most importantly, the guinea pigs immunized with rSPV/H3-2A-H1 did not show gross and micrographic lung lesions. However, the control guinea pigs experienced distinct gross and micrographic lung lesions at 7 days post-challenge. Our data suggest that the recombinant swinepox virus encoding HA1 of SIV H1N1 and H3N2 might serve as a promising candidate vaccine for protection against SIV H1N1 and H3N2 infections.

Keywords

Influenza Virus Swine Influenza Nasal Swab Swine Influenza Virus Neutralize Antibody Titer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Notes

Acknowledgments

This work was supported by the Special Fund for Public Welfare Industry of the Chinese Ministry of Agriculture (200803016) and Priority Academic Program Development of Jiangsu Higher Education Institutions.

References

  1. 1.
    Caton AJ, Brownlee GG, Yewdell JW, Gerhard W (1982) The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell 31:417–427PubMedCrossRefGoogle Scholar
  2. 2.
    Donnelly ML, Luke G, Mehrotra A, Li X, Hughes LE, Gani D, Ryan MD (2001) Analysis of the aphthovirus 2A/2B polyprotein ‘cleavage’ mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal ‘skip’. J Gen Virol 82:1013–1025PubMedGoogle Scholar
  3. 3.
    Heinen PP, Rijsewijk FA, de Boer-Luijtze EA, Bianchi AT (2002) Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus. J Gen Virol 83:1851–1859PubMedGoogle Scholar
  4. 4.
    Hessel A, Schwendinger M, Holzer GW, Orlinger KK, Coulibaly S, Savidis-Dacho H, Zips ML, Crowe BA, Kreil TR, Ehrlich HJ, Barrett PN, Falkner FG (2011) Vectors based on modified vaccinia Ankara expressing influenza H5N1 hemagglutinin induce substantial cross-clade protective immunity. PloS one 6:e16247PubMedCrossRefGoogle Scholar
  5. 5.
    Hghihghi HR, Read LR, Mohammadi H, Pei Y, Ursprung C, Nagy E, Behboudi S, Haeryfar SM, Sharif S (2011) Characterization of host responses against a recombinant fowlpox virus-vectored vaccine expressing the hemagglutinin antigen of an avian influenza virus. Clin Vaccine Immunol 17:454–463CrossRefGoogle Scholar
  6. 6.
    Ito T (2000) Interspecies transmission and receptor recognition of influenza A viruses. Microbiol Immunol 44:423–430PubMedGoogle Scholar
  7. 7.
    Larsen DL, Karasin A, Zuckermann F, Olsen CW (2000) Systemic and mucosal immune responses to H1N1 influenza virus infection in pigs. Vet Microbiol 74:117–131PubMedCrossRefGoogle Scholar
  8. 8.
    Lin HX, Huang DY, Wang Y, Lu CP, Fan HJ (2011) A novel vaccine against Streptococcus equi ssp. zooepidemicus infections: the recombinant swinepox virus expressing M-like protein. Vaccine 29:7027–7034PubMedCrossRefGoogle Scholar
  9. 9.
    Ma W, Vincent AL, Lager KM, Janke BH, Henry SC, Rowland RR, Hesse RA, Richt JA (2010) Identification and characterization of a highly virulent triple reassortant H1N1 swine influenza virus in the United States. Virus genes 40:28–36PubMedCrossRefGoogle Scholar
  10. 10.
    Manicassamy B, Medina RA, Hai R, Tsibane T, Stertz S, Nistal-Villan E, Palese P, Basler CF, Garcia-Sastre A (2011) Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines. PLoS Pathog 6:e1000745CrossRefGoogle Scholar
  11. 11.
    Masic A, Lu X, Li J, Mutwiri GK, Babiuk LA, Brown EG, Zhou Y (2011) Immunogenicity and protective efficacy of an elastase-dependent live attenuated swine influenza virus vaccine administered intranasally in pigs. Vaccine 28:7098–7108CrossRefGoogle Scholar
  12. 12.
    Masic A, Booth JS, Mutwiri GK, Babiuk LA, Zhou Y (2009) Elastase-dependent live attenuated swine influenza A viruses are immunogenic and confer protection against swine influenza A virus infection in pigs. J Virol 83:10198–10210PubMedCrossRefGoogle Scholar
  13. 13.
    Moorkamp L, Beineke A, Kaim U, Diesterbeck U, Urstadt S, Czerny CP, Ruberg H, Grosse Beilage E (2008) Swinepox–skin disease with sporadic occurrence. Dtw 115:162–166Google Scholar
  14. 14.
    Ryman KD, White LJ, Johnston RE, Klimstra WB (2002) Effects of PKR/RNase L-dependent and alternative antiviral pathways on alphavirus replication and pathogenesis. Viral Immunol 15:53–76PubMedCrossRefGoogle Scholar
  15. 15.
    Szymczak AL, Workman CJ, Wang Y, Vignali KM, Dilioglou S, Vanin EF, Vignali DA (2004) Correction of multi-gene deficiency in vivo using a single ‘self-cleaving’ 2A peptide-based retroviral vector. Nat Biotechnol 22:589–594PubMedCrossRefGoogle Scholar
  16. 16.
    Tian ZJ, Zhou GH, Zheng BL, Qiu HJ, Ni JQ, Yang HL, Yin XN, Hu SP, Tong GZ (2006) A recombinant pseudorabies virus encoding the HA gene from H3N2 subtype swine influenza virus protects mice from virulent challenge. Vet Immunol Immunop 111:211–218CrossRefGoogle Scholar
  17. 17.
    Torres V, Barra L, Garcés F, Ordenes K, Leal-Ortiz S, Garner CC, Fernandez F, Zamorano P (2010) A bicistronic lentiviral vector based on the 1D/2A sequence of foot-and-mouth disease virus expresses proteins stoichiometrically. J Biotechnol 146:138–142PubMedCrossRefGoogle Scholar
  18. 18.
    Tripathy DN (1999) Swinepox virus as a vaccine vector for swine pathogens. Adv Vet Med 41:463–480PubMedCrossRefGoogle Scholar
  19. 19.
    van der Leek ML, Feller JA, Sorensen G, Isaacson W, Adams CL, Borde DJ, Pfeiffer N, Tran T, Moyer RW, Gibbs EP (1994) Evaluation of swinepox virus as a vaccine vector in pigs using an Aujeszky’s disease (pseudorabies) virus gene insert coding for glycoproteins gp50 and gp63. Vet Rec 134:13–18PubMedCrossRefGoogle Scholar
  20. 20.
    Van Reeth K, Braeckmans D, Cox E, Van Borm S, van den Berg T, Goddeeris B, De Vleeschauwer A (2009) Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus. Vaccine 27:6330–6339PubMedCrossRefGoogle Scholar
  21. 21.
    Webster RG, Sharp GB, Claas EC (1995) Interspecies transmission of influenza viruses. Am J Resp Crit Care 152:S25–S30Google Scholar
  22. 22.
    Wesley RD, Tang M, Lager KM (2004) Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus. Vaccine 22:3427–3434PubMedCrossRefGoogle Scholar
  23. 23.
    Xu J, Huang D, Liu S, Lin H, Zhu H, Liu B, Lu C (2012) Immune responses and protection efficacy of a recombinant swinepox virus expressing HA1 against swine H3N2 influenza virus in mice and pigs. Virus Res 167:188–195PubMedCrossRefGoogle Scholar
  24. 24.
    Xu J, Huang D, Liu S, Lin H, Zhu H, Liu B, Lu C (2012) Immune responses and protective efficacy of a recombinant swinepox virus expressing HA1 against swine H1N1 influenza virus in mice and pigs. Vaccine 30:3119–3125PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 2012

Authors and Affiliations

  • Jiarong Xu
    • 1
  • Deji Yang
    • 1
  • Dongyan Huang
    • 1
    • 2
  • Jiaping Xu
    • 3
  • Shichao Liu
    • 1
  • Huixing Lin
    • 1
  • Haodan Zhu
    • 1
  • Bao Liu
    • 1
  • Chengping Lu
    • 1
  1. 1.College of Veterinary MedicineNanjing Agricultural UniversityNanjingChina
  2. 2.College of Animal Science and TechnologyJiangxi Agricultural UniversityNanchangChina
  3. 3.College of Foreign StudiesNanjing Agricultural UniversityNanjingChina

Personalised recommendations